Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

High level discussion takes place on community pharmacy workforce crisis

Shortage of pharmacists remains a big challenge for community pharmacies as the chief executives of the national community pharmacy bodies met with senior NHS England and NHS Improvement officials to discuss the precarious situation in October-end.

In the last few months, several pharmacy contractors have reported increased staff shortages that caused difficulties in maintaining services, leading to temporary closures in some instances.


The sector is also facing chronic shortage of other staff including van drivers and pharmacy technicians.

During the meeting, NHS England’s director for primary care, Ed Waller, and chief pharmaceutical officer Keith Ridge held talks with leaders from across the pharmacy sector on a variety of topics.

Representatives from the Company Chemists’ Association, the National Pharmacy Association, the Association of Independent Multiple pharmacies and the Pharmaceutical Services Negotiating Committee took part in the discussion.

Highlighting the critical shortage of pharmacists and pharmacy technicians in the sector, pharmacy bodies said in a joint statement: “This situation risks jeopardising patients’ access to care and cannot be allowed to continue.

“It is therefore vital that these cross-sector conversations with NHS England and NHS Improvement result in solutions to address the matter – both the immediate pinch on capacity and the longer term challenges.”

Besides contractors, the workforce crisis is a big challenge for the Local Pharmaceutical Committee (LPC), as the matter was discussed extensively at a recent LPC Conference, Alastair Buxton, director of NHS Services at PSNC said.

He added that PSNC is continuing to raise this issue, including with the pharmacy minister, along with the concerns over financial burden on contractors due to the significant rises in wages.

Buxton said: “We expect this to be a critical topic in our upcoming negotiations on Year 4 of the five-year CPCF deal, but as the cross-sector group on workforce has already identified – there are not going to be any easy, short-term fixes, and this will require long-term effort from across the sector, NHS and Government.”

All parties agreed to develop a collaborative plan to ensure availability of pharmacists and other staff in pharmacies, to guarantee uninterrupted patient care and the development of services.

More For You

Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less
NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less